Consider a matrix of factors when choosing the type of cleanroom facility.

Cleanroom Infrastructure Choices

Advanced analytics reveals process insights.

Optimizing Tech Transfer

Technology protects the supply chain from manufacturer to patient.

Countering Counterfeiters and Diverters

Expert help is crucial for drug sponsors that design their own facilities.

Best Practices for Building a Pharma Facility

Topic

Articles

With funding from the federal government, Merck will expand capacity to produce J&J’s COVID-19 vaccine.

Merck to Manufacture J&J Vaccine

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

In a pandemic, genetic vaccines offer several advantages over traditional approaches.

Genetic Vaccine Platforms Demonstrate Their Potential

Jennifer Markarian is manufacturing editor of BioPharm International.

A digital system makes real-time inventory, production, distribution, and shipping information readily accessible.

Digital Inventory Platform Improves Data Access

Integrated, paperless data systems can improve efficiency and quality.

Digital Tools Enhance Raw Material Traceability

Garima Thakur is a graduate student in the Department of Chemical Engineering at the Indian Institute of Technology New Delhi.

Anurag S. Rathore is a professor in the Department of Chemical Engineering at the Indian Institute of Technology Delhi and a member of BioPharm International's Editorial Advisory Board, Tel. +91.9650770650, asrathore@biotechcmz.com.

The need for real-time monitoring and control has spurred the development of new analytical tools.

Near Infrared Spectroscopy as a Versatile PAT Tool for Continuous Downstream Bioprocessing

AstraZeneca has announced that the mass rollout of its COVID-19 vaccine has begun via the COVAX initiative. 

AstraZeneca Progresses Rollout of COVID-19 Vaccine to Low- and Middle-Income Countries

Editor of Pharmaceutical Technology Europe

The rapid and efficient delivery of innovative treatments through the COVID-19 pandemic has demonstrated the value of collaborations within the bio/pharma industry.

Demonstrating the Value of Collaboration

More work is needed to ensure the rising demand for cell and gene therapy manufacturing capacity and required skilled workforce can be met in Europe.

Meeting CGT Demand

Distribution of the first one-dose vaccine for COVID-19 to start in early March.

J&J Vaccine Approved for Emergency Use

Currently, the facility manufactures products for oral diabetes treatment and will be expanded to increase capacity for these products.

Novo Nordisk to Invest $80 million into the Expansion of its Denmark Production Site

Aseptic/Sterile Processing

Cleanroom Equipment and Supplies

Clinical Trial Materials

Equipment

Facility Design and Engineering

Manufacturing

Cleanroom Infrastructure Choices

Optimizing Tech Transfer

Countering Counterfeiters and Diverters

Best Practices for Building a Pharma Facility